SCHEMBL16065098

SCHEMBL16065098

Cc1ccnc(OCCOCCO)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.38
▸ UHRF1 Q96T88 1/20 0.38
▸ CCR1 P32246 1/20 0.38
▸ CCR5 P51681 1/20 0.38
▸ CCR8 P51685 1/20 0.38
▸ APP P05067 5/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ SLCO1B3 Q9NPD5 1/20 0.37
▸ SLCO1B1 Q9Y6L6 1/20 0.37
▸ THRB P10828 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ NOS3 P29474 1/20 0.36
▸ NOS1 P29475 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12017657 0.90 KMT2A (0.44) UHRF1CCR1CCR5CCR8KMT2A
SCHEMBL26481706 0.83 LOX (0.41) MAPK1UHRF1CCR1CCR5CCR8
SCHEMBL21405450 0.80 MEN1 (0.37) MAPK1APPKMT2AMEN1LMNA
SCHEMBL21405465 0.80 MEN1 (0.37) MAPK1APPKMT2AMEN1LMNA
SCHEMBL17406996 0.80 MEN1 (0.37) MAPK1APPKMT2AMEN1LMNA
SCHEMBL29790345 0.80 MEN1 (0.37) MAPK1APPKMT2AMEN1LMNA
SCHEMBL29838204 0.80 MEN1 (0.37) MAPK1APPKMT2AMEN1LMNA
SCHEMBL21405346 0.80 MEN1 (0.37) MAPK1APPKMT2AMEN1LMNA
SCHEMBL29838311 0.80 MEN1 (0.37) MAPK1APPKMT2AMEN1LMNA
SCHEMBL12017658 0.79 UHRF1 (0.43) MAPK1UHRF1CCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970334-B1 MACROCYCLIC COMPOUNDS AS IRAK4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES BIOGEN MA INC (US) 2018-05-23 — — EP disclosed
WO-2014143672-A1 MACROCYCLIC COMPOUNDS AS IRAK4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES BIOGEN IDEC MA INC. (US) 2014-09-18 — — WO disclosed
Send feedback